SIRT1‐mediated deacetylation of FOXO3a transcription factor supports pro‐angiogenic activity of interferon‐deficient tumor‐associated neutrophils. Issue 7 (24th November 2021)

• Record Type: Journal Article
• Authors: Bordbari, Sharareh; Mörchen, Britta; Pylaeva, Ekaterina; Siakaeva, Elena; Spyra, Ilona; Domnich, Maksim; Droege, Freya; Kanaan, Oliver; Lang, Karl Sebastian; Schadendorf, Dirk; Lang, Stephan; Helfrich, Iris; Jablonska, Jadwiga
• Is Part Of: International journal of cancer. Volume 150:Issue 7(2022)
• Page Start: 1198
• Page End: 1211
• Publication Date: 2021-11-24
• Subjects: deacetylation -- FOXO3a -- melanoma -- pro‐angiogenic neutrophils -- SIRT1 -- tumor angiogenesis -- tumor‐associated neutrophils -- Type I IFN -- vascular normalization; Cancer -- Periodicals; Cancer -- Prevention -- Periodicals; 616.994
• DOI: 10.1002/ijc.33871
• Languages: English
• ISSNs: 0020-7136

Abstract

Abstract: Angiogenesis plays an important role during tumor growth and metastasis. We could previously show that Type I interferon (IFN)‐deficient tumor‐associated neutrophils (TANs) show strong pro‐angiogenic activity, and stimulate tumor angiogenesis and growth. However, the exact mechanism responsible for their pro‐angiogenic shift is not clear. Here, we set out to delineate the molecular mechanism and factors regulating pro‐angiogenic properties of neutrophils in the context of Type I IFN availability. We demonstrate that neutrophils from IFN‐deficient ( Ifnar1 −/− ) mice efficiently release pro‐angiogenic factors, such as VEGF, MMP9 or BV8, and thus significantly support the vascular normalization of tumors by increasing the maturation of perivascular cells. Mechanistically, we could show here that the expression of pro‐angiogenic factors in neutrophils is controlled by the transcription factor forkhead box protein O3a (FOXO3a), which activity depends on its post‐translational modifications, such as deacetylation or phosphorylation. In TANs isolated from Ifnar1 −/− mice, we observe significantly elevated SIRT1, resulting in SIRT1‐mediated deacetylation of FOXO3a, its nuclear retention and activation. Activated FOXO3a supports in turn the transcription of pro‐angiogenic genes in TANs. In the absence of SIRT1, or after its inhibition in neutrophils, elevated kinase MEK/ERK and PI3K/AKT activity is observed, leading to FOXO3a phosphorylation, cytoplasmic transfer and inactivation. In summary, we have found that FOXO3a is a key transcription factor controlling the angiogenic switch of neutrophils. Post‐translational FOXO3a modifications regulate its transcriptional activity and, as a result, the expression of pro‐angiogenic factors supporting development of vascular network in growing tumors. Therefore, targeting FOXO3a activity could provide a novel strategy of antiangiogenic targeted therapy for cancer. Abstract : What's new? Angiogenesis plays an important role in tumor growth and metastasis. Tumor‐associated neutrophils (TANs) are known to affect tumor angiogenesis, but how? In this study, the authors found that a lack of interferon‐1 (IFN‐1) activates a molecular cascade within TANs that involves Sirtuin 1 (SIRT1) and the transcription factor FOXO3a. This cascade, in turn, can stimulate the release of pro‐angiogenic factors into the tumor microenvironment. These insights into the molecular mechanisms of TAN regulation suggest new therapeutic targets for anti‐angiogenic cancer therapies.